Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A review

A. Daniele, I. Abbate, C. Oakley, P. Casamassima, E. Savino, A. Casamassima, Giancarlo Sciortino, V. Fazio, G. Gadaleta-Caldarola, A. Catino, F. Giotta, R. De Luca, R. Divella

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Matrix metalloproteinases are a family of zinc endopeptidases with proteolytic activity against the extracellular matrix components. In particular, two members of this family named Gelatinase A and B, as amply documented in the literature, play a key role in the process of tumor growth/metastasis in breast and hepatocellular carcinoma. Their activity is regulated by Tissue Inhibitor of metalloproteinases-1 and -2, which are the physiological inhibitor of Gelatinases A and B respectively. The aim of this review is to determine the current understanding of the clinical and prognostic role of Metalloproteinases-2 and -9 and their inhibitors in the course of breast cancer and liver diseases. Forty-one articles were selected from PubMed by entering the following keywords: liver diseases, breast cancer, MMP-2, TIMP-2; all articles were read and notes were made regarding the number of enrolled patients, pathology, measures, results and these data were used to write this review. Over-expression of both gelatinases is associated with the relapse of disease, metastasis, shorter overall survival in breast cancer and hepatocellular carcinoma and invasion and progression to tumors in chronic liver diseases, and MMPs/TIMPs ratio could be useful in the follow-up of these patients.

Original languageEnglish
Pages (from-to)91-101
Number of pages11
JournalInternational Journal of Biochemistry and Cell Biology
Volume77
Issue number(PT A)
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Breast Diseases
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Liver Neoplasms
Liver
Liver Diseases
Matrix Metalloproteinases
Breast Neoplasms
Tissue Inhibitor of Metalloproteinase-2
Tumors
Hepatocellular Carcinoma
Gelatinases
Endopeptidases
Tissue Inhibitor of Metalloproteinase-1
Neoplasm Metastasis
Metalloproteases
Pathology
Zinc
PubMed
Extracellular Matrix

Keywords

  • Breast carcinoma
  • Hcc and liver disease
  • MMPs
  • TIMPs

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

@article{7f66d1b0d5614d5a8007e7976842e7ef,
title = "Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A review",
abstract = "Matrix metalloproteinases are a family of zinc endopeptidases with proteolytic activity against the extracellular matrix components. In particular, two members of this family named Gelatinase A and B, as amply documented in the literature, play a key role in the process of tumor growth/metastasis in breast and hepatocellular carcinoma. Their activity is regulated by Tissue Inhibitor of metalloproteinases-1 and -2, which are the physiological inhibitor of Gelatinases A and B respectively. The aim of this review is to determine the current understanding of the clinical and prognostic role of Metalloproteinases-2 and -9 and their inhibitors in the course of breast cancer and liver diseases. Forty-one articles were selected from PubMed by entering the following keywords: liver diseases, breast cancer, MMP-2, TIMP-2; all articles were read and notes were made regarding the number of enrolled patients, pathology, measures, results and these data were used to write this review. Over-expression of both gelatinases is associated with the relapse of disease, metastasis, shorter overall survival in breast cancer and hepatocellular carcinoma and invasion and progression to tumors in chronic liver diseases, and MMPs/TIMPs ratio could be useful in the follow-up of these patients.",
keywords = "Breast carcinoma, Hcc and liver disease, MMPs, TIMPs",
author = "A. Daniele and I. Abbate and C. Oakley and P. Casamassima and E. Savino and A. Casamassima and Giancarlo Sciortino and V. Fazio and G. Gadaleta-Caldarola and A. Catino and F. Giotta and {De Luca}, R. and R. Divella",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.biocel.2016.06.002",
language = "English",
volume = "77",
pages = "91--101",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "(PT A)",

}

TY - JOUR

T1 - Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases

T2 - A review

AU - Daniele, A.

AU - Abbate, I.

AU - Oakley, C.

AU - Casamassima, P.

AU - Savino, E.

AU - Casamassima, A.

AU - Sciortino, Giancarlo

AU - Fazio, V.

AU - Gadaleta-Caldarola, G.

AU - Catino, A.

AU - Giotta, F.

AU - De Luca, R.

AU - Divella, R.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Matrix metalloproteinases are a family of zinc endopeptidases with proteolytic activity against the extracellular matrix components. In particular, two members of this family named Gelatinase A and B, as amply documented in the literature, play a key role in the process of tumor growth/metastasis in breast and hepatocellular carcinoma. Their activity is regulated by Tissue Inhibitor of metalloproteinases-1 and -2, which are the physiological inhibitor of Gelatinases A and B respectively. The aim of this review is to determine the current understanding of the clinical and prognostic role of Metalloproteinases-2 and -9 and their inhibitors in the course of breast cancer and liver diseases. Forty-one articles were selected from PubMed by entering the following keywords: liver diseases, breast cancer, MMP-2, TIMP-2; all articles were read and notes were made regarding the number of enrolled patients, pathology, measures, results and these data were used to write this review. Over-expression of both gelatinases is associated with the relapse of disease, metastasis, shorter overall survival in breast cancer and hepatocellular carcinoma and invasion and progression to tumors in chronic liver diseases, and MMPs/TIMPs ratio could be useful in the follow-up of these patients.

AB - Matrix metalloproteinases are a family of zinc endopeptidases with proteolytic activity against the extracellular matrix components. In particular, two members of this family named Gelatinase A and B, as amply documented in the literature, play a key role in the process of tumor growth/metastasis in breast and hepatocellular carcinoma. Their activity is regulated by Tissue Inhibitor of metalloproteinases-1 and -2, which are the physiological inhibitor of Gelatinases A and B respectively. The aim of this review is to determine the current understanding of the clinical and prognostic role of Metalloproteinases-2 and -9 and their inhibitors in the course of breast cancer and liver diseases. Forty-one articles were selected from PubMed by entering the following keywords: liver diseases, breast cancer, MMP-2, TIMP-2; all articles were read and notes were made regarding the number of enrolled patients, pathology, measures, results and these data were used to write this review. Over-expression of both gelatinases is associated with the relapse of disease, metastasis, shorter overall survival in breast cancer and hepatocellular carcinoma and invasion and progression to tumors in chronic liver diseases, and MMPs/TIMPs ratio could be useful in the follow-up of these patients.

KW - Breast carcinoma

KW - Hcc and liver disease

KW - MMPs

KW - TIMPs

UR - http://www.scopus.com/inward/record.url?scp=84975079549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975079549&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2016.06.002

DO - 10.1016/j.biocel.2016.06.002

M3 - Article

AN - SCOPUS:84975079549

VL - 77

SP - 91

EP - 101

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - (PT A)

ER -